News

Manchester man sentenced to prison for strangulation

Manchester man sentenced to prison for strangulation

Photo: clipart.com


MANCHESTER, N.H.- Authorities say Aaron Plourde has been sentenced to 3½ to 7 years in prison following his conviction on multiple felony and misdemeanor charges, including strangulation and witness tampering,

According to court documents on September 21, 2025, Plourde went to the victim’s residence and a verbal argument quickly escalated into a violent physical attack that, including attempting to strangle the victim.

A jury convicted Plourde of; two counts of Second-Degree Assault – Strangulation, two counts of Solicitation to Commit Witness Tampering and Five misdemeanor charges

Recent Headlines

1 day ago in National

Terrorism trial opens in stabbing of author Salman Rushdie

The man convicted of trying to kill Salman Rushdie spent years researching the writer's whereabouts before stabbing him on a lecture stage, federal prosecutors said Wednesday at the opening of his federal terrorism trial.

3 days ago in National, Trending

Social media influencers Andrew and Tristan Tate expected in Miami court

Influencer brothers Andrew and Tristan Tate are scheduled to appear before a federal magistrate in Miami on Monday after they were arrested to face rape and sex trafficking charges in the United Kingdom.

6 days ago in Lifestyle, National, Trending

Lettuce at Taco Bell in 5 states confirmed as a source of diarrhea-causing parasite

Federal health officials have identified lettuce from Mexico served at Taco Bell locations across five U.S. states as a source of the widespread outbreak of...

6 days ago in National

China warns of reciprocal countermeasures after US shortens foreign journalist visas

By DIDI TANG Associated Press WASHINGTON (AP) — The Trump administration announced Thursday it will drastically shorten visas for foreign…

1 week ago in National

An experimental Alzheimer’s drug shows some promise as researchers hunt new approaches

An experimental drug might help slow early Alzheimer's disease in a markedly different way than today's treatments — by lowering levels of a brain protein called tau, researchers reported Tuesday.